EUVIMEDEUVIMED entdecken
Open Access

BEEAF 2 Score: A New Risk Stratification Score for Patients With Stage B Heart Failure From the KUNIUMI Registry Chronic Cohort

Susumu Odajima iD, Wataru Fujimoto, Misa Takegami iD, Kunihiro Nishimura iD, Masamichi Iwasaki, Masanori Okuda iD, Akihide Konishi, Masakazu Shinohara iD, Manabu Nagao iD, Ryuji Toh, Ken-Ichi Hirata, Hidekazu Tanaka iD

Journal of the American Heart Association · 2024

DOI: 10.1161/jaha.124.034793 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Journal of the American Heart Association, 2024. Verfasst von Susumu Odajima und 11 weiteren Autor:innen. Beteiligte Einrichtung: Division of Cardiovascular Medicine, Department of Internal Medicine Kobe University Graduate School of Medicine Kobe Japan. Hauptthemen laut MEDLINE: Heart Failure, Registries. Die Arbeit wurde bisher 12-mal zitiert (Crossref) und nennt 22 Literaturangaben. Der Volltext ist frei in PubMed Central verfügbar.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Background

Stage B heart failure (HF) refers to structural heart disease without signs or symptoms of HF, so that early intervention may delay or prevent the onset of overt HF. However, stage B HF is a very broad concept, and risk stratification of such patients can be challenging. Methods and Results We conducted a prospective study of data for 1646 consecutive patients with HF from the KUNIUMI (Kobe University Heart Failure Registry in Awaji Medical Center) registry chronic cohort. The definition of HF stages was based on current guidelines for classification of 29 patients as stage A HF, 761 as stage B HF, 827 as stage C HF, and 29 patients as stage D HF. The primary end point was the time‐to‐first‐event defined as cardiovascular death or HF hospitalization within 2.0 years of follow‐up. A maximum of 6 adjustment factor points was assigned based on Cox proportional hazards analysis findings for the hazard ratio (HR) of independent risk factors for the primary end point: 1 point for anemia, estimated glomerular filtration rate 14, and 2 points for clinical frailty scale >3. Patients with stage B HF were stratified into 3 groups, low risk (0–1 points), moderate risk (2–3 points), and high risk (4–6 points). Based on this scoring system (BEEAF 2 [brain natriuretic peptide, estimated glomerular filtration rate, ratio of early transmitral flow velocity to early diastolic mitral annular velocity, anemia, and frailty]), the outcome was found to become worse in accordance with risk level. High‐risk patients with stage B HF and patients with stage C HF showed similar outcomes.

Conclusions

Our scoring system offers an easy‐to‐use evaluation of risk stratification for patients with stage B HF.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Heart FailureRegistriesHumansMaleFemaleRisk AssessmentAgedProspective StudiesMiddle AgedJapanRisk FactorsPrognosisNatriuretic Peptide, BrainAged, 80 and overSeverity of Illness IndexGlomerular Filtration RateTime Factors

Stichwörter der Autor:innen

echocardiographypreclinical heart failurerisk stratificationstage B heart failure

Substanzen

Natriuretic Peptide, Brain

Autor:innen und Institutionen

  • Division of Cardiovascular Medicine, Department of Internal Medicine Kobe University Graduate School of Medicine Kobe Japan.
  • Department of Cardiology Hyogo Prefectural Awaji Medical Center Sumoto Japan.
  • Department of Preventive Medicine and Epidemiology National Cerebral and Cardiovascular Center Suita Japan.
  • Department of Public Health and Health Policy, Graduate School of Medicine The University of Tokyo Japan.
  • Clinical and Translational Research Center Kobe University Hospital Kobe Japan.
  • Division of Epidemiology Kobe University Graduate School of Medicine Kobe Japan.

ORCID-Profile: Susumu Odajima, Misa Takegami, Kunihiro Nishimura, Masanori Okuda, Masakazu Shinohara, Manabu Nagao, Hidekazu Tanaka

Zitieren

APA

Odajima, S., Fujimoto, W., Takegami, M., Nishimura, K., Iwasaki, M., Okuda, M., Konishi, A., Shinohara, M., Nagao, M., Toh, R., Hirata, K. I., & Tanaka, H. (2024). BEEAF 2 Score: A New Risk Stratification Score for Patients With Stage B Heart Failure From the KUNIUMI Registry Chronic Cohort. Journal of the American Heart Association. https://doi.org/10.1161/jaha.124.034793

Vancouver

Odajima S, Fujimoto W, Takegami M, Nishimura K, Iwasaki M, Okuda M, et al. BEEAF 2 Score: A New Risk Stratification Score for Patients With Stage B Heart Failure From the KUNIUMI Registry Chronic Cohort. Journal of the American Heart Association. 2024. doi:10.1161/jaha.124.034793

BibTeX
@article{Odajima2024,
  author = {Odajima, Susumu and Fujimoto, Wataru and Takegami, Misa and Nishimura, Kunihiro and Iwasaki, Masamichi and Okuda, Masanori and Konishi, Akihide and Shinohara, Masakazu and Nagao, Manabu and Toh, Ryuji and Hirata, Ken-Ichi and Tanaka, Hidekazu},
  title = {BEEAF 2 Score: A New Risk Stratification Score for Patients With Stage B Heart Failure From the KUNIUMI Registry Chronic Cohort},
  journal = {Journal of the American Heart Association},
  year = {2024},
  doi = {10.1161/jaha.124.034793}
}
Kostenlos starten →